Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells

Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells

US Patent 12351815 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered human-endogenous virus-like particles and methods of use thereof for 2025
Engineered human-endogenous virus-like particles and methods of use thereof for 2025
Engineered human-endogenous virus-like particles and methods of use thereof for 2025
Engineered human-endogenous virus-like particles and methods of use thereof for 2025
Enhanced virus-like particles and methods of use thereof for delivery to cells2025
Enhanced virus-like particles and methods of use thereof for delivery to cells2025
Methods for increasing efficiency of nuclease-induced homology-directed repair2025
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2025
Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf12025
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2024
Variants of Cpf1 (Cas12a) with altered PAM specificity2024
TAL-Tet1 fusion proteins and methods of use thereof2024